Shoulder Innovations Launches InSet™ I-135RFX Humeral Stem
Shoulder Innovations, Inc. has announced the full commercial launch of the InSet™ I-135RFX Humeral Stem, following a successful limited market release and FDA clearance for additional fracture indications. This product is part of their I-Series product line, aimed at transforming shoulder surgical care.
Latest Addition to I-Series Product Line Follows a Successful Limited Market Release and FDA
Clearance of Additional Fracture Indications
GRAND RAPIDS, Mich., April 27, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (Shoulder Innovations, or the Company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced full commercial launch of the InSet™ I-135RFX Humeral Stem (“InSet™ I-135RFX”).
